| Family: | Global X |
| Name: | Genomics & Biotechnology ETF |
| Inception Date: | 5-Apr-2019 |
| Termination Date: | |
| Investment Objective: | The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology. |
| Prospectus | |
| Top 10 Holdings | ||
| MODERNA INC | MRNA | 8.4400% |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | 6.7600% |
| PRAXIS PRECISION MEDICINES I | PRAX | 6.6700% |
| ILLUMINA INC | ILMN | 5.3400% |
| GUARDANT HEALTH INC | GH | 4.5100% |
| NATERA INC | NTRA | 4.1300% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 4.0900% |
| VERTEX PHARMACEUTICALS INC | VRTX | 4.0600% |
| BIONTECH SE-ADR | BNTX | 3.7000% |
| BIO-TECHNE CORP | TECH | 3.6200% |
| Top 10 Holdings Weight: | 51.3% |
| Number of Holdings: | 51 |
| Shares Outstanding: | 1,124,672 |
| Total Net Assets: | 52,747,120 |
| NAV: | 46.89 |
| Net Expense Ratio: | 0.50% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Global |
